Neutrophil-to-lymphocyte ratio, platelet-to- lymphocyte ratio and mean platelet volume in lupus nephritis (CROSBI ID 719389)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Knežević, Tamara ; Padjen, Ivan ; Bulimbašić, Stela ; Ćorić, Marijana ; Ivković, Vanja ; Laganović, Mario ; Anić, Branimir
engleski
Neutrophil-to-lymphocyte ratio, platelet-to- lymphocyte ratio and mean platelet volume in lupus nephritis
Background: A number of blood count parameters are associated with inflammatory and autoimmune diseases. There is discordant evidence whether neutrophil-to-lymphocyte ratio (NLR), platelet-to- lymphocyte ratio (PLR) and mean platelet volume (MPV) might reflect inflammatory response and have prognostic value in SLE patients. However, the studies examining the potential role of these markers in LN are missing. Objectives: To examine NLR, PLR and MPV at the time of biopsy in patients with LN and evaluate their association with prognosis. Methods: In this retrospective study we analyzed the demographic, histologic, laboratory and clinical characteristics of patients with biopsy- proven LN diagnosed between 2011 and 2020. All patients met the 1997 revised American College of Rheumatology classification criteria for SLE. Complete remission was defined as proteinuria <0.5 g/day and serum creatinine within 10% from baseline, and partial remission as more than 50% reduction in proteinuria to sub-nephrotic levels and serum creatinine within 10% from baseline. Results: We have included 55 patients (80% women) with biopsy-proven LN (age at biopsy 38±13 years). On renal histology, one patient was class I LN, two patients were class II, 7 were class III, 5 were class III+V, 23 were class IV, two were class IV+V, 11 class VI and 4 had other features. Median baseline NLR was 3.64 (IQR: 1.85, 6.93), PLR was 167 (IQR: 116, 300) and MPV was 10.0 (IQR: 9.2, 10.8). There were no differences in any of the three parameters between different classess of LN (all p>0.05). Eighteen patients achieved complete remission (CR), 16 partial remission and 21 did not achieve remission. None progressed to ESRD and two patients died, both from sepsis. There no differences in NLR, PLR and MPV at the time of biopsy between group which achieved CR/PR vs. no remission (all p>0.05 ; Figure 1 ). We constructed a thorough multivariate regression model which showed that neither NLR, PLR or MPV are predictors of renal remission in LN. Conclusion: NLR, PLR and MPV are not useful prognostic markers in predicting renal remission in LN.
lupus nephritis ; systemic lupus erythematosus ; complete blood cell count
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
1199-1199.
2021.
nije evidentirano
objavljeno
10.1136/annrheumdis-2021-eular.4164
Podaci o matičnoj publikaciji
Annals of rheumatic diseases
0003-4967
1468-2060
Podaci o skupu
European congress of rheumatolog (EULAR 2021)
ostalo
02.06.2021-05.06.2021
online
Povezanost rada
Kliničke medicinske znanosti